{
    "2023-03-31": {
        "Tax Effect Of Unusual Items": 0.0,
        "Tax Rate For Calcs": 0.0,
        "Normalized EBITDA": -14795000.0,
        "Total Unusual Items": 233000.0,
        "Total Unusual Items Excluding Goodwill": 233000.0,
        "Net Income From Continuing Operation Net Minority Interest": -16795000.0,
        "Reconciled Depreciation": 802000.0,
        "Reconciled Cost Of Revenue": 1801000.0,
        "EBIT": -15364000.0,
        "Net Interest Income": -1011000.0,
        "Interest Expense": 1431000.0,
        "Interest Income": 420000.0,
        "Normalized Income": -17028000.0,
        "Net Income From Continuing And Discontinued Operation": -16795000.0,
        "Total Expenses": 18874000.0,
        "Total Operating Income As Reported": -16062000.0,
        "Diluted Average Shares": 9830100.0,
        "Basic Average Shares": 9830100.0,
        "Diluted EPS": -1.7,
        "Basic EPS": -1.7,
        "Diluted NI Availto Com Stockholders": -16795000.0,
        "Net Income Common Stockholders": -16795000.0,
        "Net Income": -16795000.0,
        "Net Income Including Noncontrolling Interests": -16795000.0,
        "Net Income Continuous Operations": -16795000.0,
        "Tax Provision": 0.0,
        "Pretax Income": -16795000.0,
        "Other Income Expense": 278000.0,
        "Other Non Operating Income Expenses": 45000.0,
        "Special Income Charges": 0.0,
        "Other Special Charges": NaN,
        "Gain On Sale Of Security": 233000.0,
        "Net Non Operating Interest Income Expense": -1011000.0,
        "Interest Expense Non Operating": 1431000.0,
        "Interest Income Non Operating": 420000.0,
        "Operating Income": -16062000.0,
        "Operating Expense": 17073000.0,
        "Research And Development": 6968000.0,
        "Selling General And Administration": 10105000.0,
        "Gross Profit": 1011000.0,
        "Cost Of Revenue": 1801000.0,
        "Total Revenue": 2812000.0,
        "Operating Revenue": 2812000.0
    },
    "2022-12-31": {
        "Tax Effect Of Unusual Items": 1749.411844,
        "Tax Rate For Calcs": 0.005176,
        "Normalized EBITDA": -12979000.0,
        "Total Unusual Items": 338000.0,
        "Total Unusual Items Excluding Goodwill": 338000.0,
        "Net Income From Continuing Operation Net Minority Interest": -14800000.0,
        "Reconciled Depreciation": 793000.0,
        "Reconciled Cost Of Revenue": 2322000.0,
        "EBIT": -13434000.0,
        "Net Interest Income": -1043000.0,
        "Interest Expense": 1443000.0,
        "Interest Income": 400000.0,
        "Normalized Income": -15136250.588156,
        "Net Income From Continuing And Discontinued Operation": -14800000.0,
        "Total Expenses": 17123000.0,
        "Total Operating Income As Reported": -14151000.0,
        "Diluted Average Shares": NaN,
        "Basic Average Shares": NaN,
        "Diluted EPS": NaN,
        "Basic EPS": NaN,
        "Diluted NI Availto Com Stockholders": -14800000.0,
        "Net Income Common Stockholders": -14800000.0,
        "Net Income": -14800000.0,
        "Net Income Including Noncontrolling Interests": -14800000.0,
        "Net Income Continuous Operations": -14800000.0,
        "Tax Provision": -77000.0,
        "Pretax Income": -14877000.0,
        "Other Income Expense": 317000.0,
        "Other Non Operating Income Expenses": -21000.0,
        "Special Income Charges": 0.0,
        "Other Special Charges": 0.0,
        "Gain On Sale Of Security": 338000.0,
        "Net Non Operating Interest Income Expense": -1043000.0,
        "Interest Expense Non Operating": 1443000.0,
        "Interest Income Non Operating": 400000.0,
        "Operating Income": -14151000.0,
        "Operating Expense": 14801000.0,
        "Research And Development": 6030000.0,
        "Selling General And Administration": 8771000.0,
        "Gross Profit": 650000.0,
        "Cost Of Revenue": 2322000.0,
        "Total Revenue": 2972000.0,
        "Operating Revenue": 2972000.0
    },
    "2022-09-30": {
        "Tax Effect Of Unusual Items": 0.0,
        "Tax Rate For Calcs": 0.0,
        "Normalized EBITDA": -13974000.0,
        "Total Unusual Items": -261000.0,
        "Total Unusual Items Excluding Goodwill": -261000.0,
        "Net Income From Continuing Operation Net Minority Interest": -15705000.0,
        "Reconciled Depreciation": 772000.0,
        "Reconciled Cost Of Revenue": 2190000.0,
        "EBIT": -15007000.0,
        "Net Interest Income": -625000.0,
        "Interest Expense": 698000.0,
        "Interest Income": 73000.0,
        "Normalized Income": -15444000.0,
        "Net Income From Continuing And Discontinued Operation": -15705000.0,
        "Total Expenses": 17730000.0,
        "Total Operating Income As Reported": -14770000.0,
        "Diluted Average Shares": 8701100.0,
        "Basic Average Shares": 8701100.0,
        "Diluted EPS": -1.8,
        "Basic EPS": -1.8,
        "Diluted NI Availto Com Stockholders": -15705000.0,
        "Net Income Common Stockholders": -15705000.0,
        "Net Income": -15705000.0,
        "Net Income Including Noncontrolling Interests": -15705000.0,
        "Net Income Continuous Operations": -15705000.0,
        "Tax Provision": 0.0,
        "Pretax Income": -15705000.0,
        "Other Income Expense": -310000.0,
        "Other Non Operating Income Expenses": -49000.0,
        "Special Income Charges": 0.0,
        "Other Special Charges": NaN,
        "Gain On Sale Of Security": -261000.0,
        "Net Non Operating Interest Income Expense": -625000.0,
        "Interest Expense Non Operating": 698000.0,
        "Interest Income Non Operating": 73000.0,
        "Operating Income": -14770000.0,
        "Operating Expense": 15540000.0,
        "Research And Development": 7285000.0,
        "Selling General And Administration": 8255000.0,
        "Gross Profit": 770000.0,
        "Cost Of Revenue": 2190000.0,
        "Total Revenue": 2960000.0,
        "Operating Revenue": 2960000.0
    },
    "2022-06-30": {
        "Tax Effect Of Unusual Items": 0.0,
        "Tax Rate For Calcs": 0.0,
        "Normalized EBITDA": -17221000.0,
        "Total Unusual Items": 950000.0,
        "Total Unusual Items Excluding Goodwill": 950000.0,
        "Net Income From Continuing Operation Net Minority Interest": -17803000.0,
        "Reconciled Depreciation": 819000.0,
        "Reconciled Cost Of Revenue": 2781000.0,
        "EBIT": -17090000.0,
        "Net Interest Income": -657000.0,
        "Interest Expense": 713000.0,
        "Interest Income": 56000.0,
        "Normalized Income": -18753000.0,
        "Net Income From Continuing And Discontinued Operation": -17803000.0,
        "Total Expenses": 21850000.0,
        "Total Operating Income As Reported": -17989000.0,
        "Diluted Average Shares": 7623100.0,
        "Basic Average Shares": 7623100.0,
        "Diluted EPS": -2.4,
        "Basic EPS": -2.4,
        "Diluted NI Availto Com Stockholders": -17803000.0,
        "Net Income Common Stockholders": -17803000.0,
        "Net Income": -17803000.0,
        "Net Income Including Noncontrolling Interests": -17803000.0,
        "Net Income Continuous Operations": -17803000.0,
        "Tax Provision": 0.0,
        "Pretax Income": -17803000.0,
        "Other Income Expense": 843000.0,
        "Other Non Operating Income Expenses": -107000.0,
        "Special Income Charges": 919000.0,
        "Other Special Charges": -919000.0,
        "Gain On Sale Of Security": 31000.0,
        "Net Non Operating Interest Income Expense": -657000.0,
        "Interest Expense Non Operating": 713000.0,
        "Interest Income Non Operating": 56000.0,
        "Operating Income": -17989000.0,
        "Operating Expense": 19069000.0,
        "Research And Development": 7576000.0,
        "Selling General And Administration": 11493000.0,
        "Gross Profit": 1080000.0,
        "Cost Of Revenue": 2781000.0,
        "Total Revenue": 3861000.0,
        "Operating Revenue": 3861000.0
    }
}